clinical: Stem cell transplantation Flashcards
Types of transplant
Syngeneic: from twins
Autologous: from patient
Allogeneic: from a match
Xenogeneic: from different species
4 reasons for bone marrow transplant
Replace abnormal bt nonmalignant lymphohem system from a normal donor
Ablate to treat a malignancy
Immunotherapy
Gene Therapy
Process for both Allogeneic and Autologous
Chemo-radio therapy
Pancytopenic Stage
Engraftment
Difference in preservation between autologous and allogeneic
Autologous is cryopreserved whereas Allogeneic is preferred fresh not frozen
Drug used for conditioning to eradicate hyperplastic host hematopoesis
Cyclophosphamide
Indications from Stem cell transplant
Non-hodgkins lymphoma included relapsed diffuse large b cell lymphoma
Multiple myeloma (FIRST LINE AND IMPROVES SURVIVAL)
Allogeneic stem cell transplant indications
Intermediate or High risk AML
Ph+ ALL in adults less than 60
CML (not first line)
Refractory Non-hodgkins leukemia
Aplastic Anemia: for less than 20 yo, sibling match 20-40
Non-malignant Disease: thalassemias and sickle cell
Severe Myeloproliferative Disorders: younger and with match
Myeloproliferative Syndrome advanced disease w/ matched donor and transplant eligible
What Non malignant disease can be treated with allogeneic stem cells
Thalassemias and Sickle Cell
Low grade lymphomas
Follicular Lymphoma
CLL/SLL
Aggressive Lymphomas
Diffuse large b cell lymphoma
Mantle Cell Lymphoma
Highly aggressive Lymphoma
Burkitt’s Lymphoma
Lymphoblastic Lymphoma
Acute Myeloid Leukemia good Cytogenetics
t(15;17)
t(8;21)
Inversion 16
FLT3-; NPM1+
FLT3-;NPM1-; CEPBA double mutant
Acute Myeloid Leukemia Intermeduate Cytogenetics
Normal
Trisomy 8
Trisomy 21
High risk Cytogenetics for Acute Myeloid Leukemia
-5, -7, 11q23
FLT3+
Complex
Secondary AML or t-AML, MDS-AML
Philadelphia + ALL is a definitive indication for
stem cell transplant in CR1